371 related articles for article (PubMed ID: 5566718)
1. Indications for adrenergic stimulators in shock.
Mills LC; Moyer JH
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
[No Abstract] [Full Text] [Related]
2. The dilemma of vasopressors and vasodilators in the therapy of shock.
Shoemaker WC; Brown RS
Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
[No Abstract] [Full Text] [Related]
3. [The use of sympathomimetics and sympatholytics in shock].
Torsti P
Duodecim; 1971; 87(4):297-304. PubMed ID: 5547048
[No Abstract] [Full Text] [Related]
4. Vasopressor agents in shock.
Moyer JH; Mills LC
Am J Nurs; 1975 Apr; 75(4):620-5. PubMed ID: 1039254
[TBL] [Abstract][Full Text] [Related]
5. Adrenergic agonists and antagonists in the treatment of hypovolemic shock.
Williamson M
J Am Med Womens Assoc; 1969 Dec; 24(12):951-6 passim. PubMed ID: 4391032
[No Abstract] [Full Text] [Related]
6. Current status of the treatment of shock complicating acute myocardial infarction.
Friedberg CK
J Trauma; 1969 Feb; 9(2):141-2. PubMed ID: 5763330
[No Abstract] [Full Text] [Related]
7. Hemodynamic effects of sympathomimetic amines in clinical shock.
Brown RS; Carey JS; Woodward NW; Mohr PA; Shoemaker WC
Surg Gynecol Obstet; 1966 Feb; 122(2):303-7. PubMed ID: 5901296
[No Abstract] [Full Text] [Related]
8. Treatment of severe shock with phenoxybenzamine.
Hardaway RM
Surg Gynecol Obstet; 1980 Dec; 151(6):725-34. PubMed ID: 7444723
[TBL] [Abstract][Full Text] [Related]
9. [Drugs in shock treatment].
Dietzman RH; Motsay GJ; Lillehei RC
Internist (Berl); 1971 Mar; 12(3):103-7. PubMed ID: 4927712
[No Abstract] [Full Text] [Related]
10. [Drug therapy in cardiogenic shock].
Wenger R
Int J Clin Pharmacol; 1973 Apr; 7(2):127-31. PubMed ID: 4147221
[No Abstract] [Full Text] [Related]
11. [Basic principles of the therapy of shock].
Schröder R
Minerva Med; 1972 Dec; 63(93):5243-6. PubMed ID: 4646406
[No Abstract] [Full Text] [Related]
12. Physiologic basis for the therapeutic use of catecholamines.
Rosenblum R
Am Heart J; 1974 Apr; 87(4):527-30. PubMed ID: 4817111
[No Abstract] [Full Text] [Related]
13. Effects of vasoactive drugs on oxygen consumption in endotoxin shock.
Anas P; Hardy JD
Arch Surg; 1969 Feb; 98(2):189-93. PubMed ID: 4885452
[No Abstract] [Full Text] [Related]
14. [Glucocorticoids in prophylaxis and therapy of different kinds of shock].
Beickert A
Dtsch Gesundheitsw; 1970 Oct; 25(44):2061-7. PubMed ID: 4923491
[No Abstract] [Full Text] [Related]
15. Pressor agents in cardiogenic shock.
Corday E; Lillehei RC
Am J Cardiol; 1969 Jun; 23(6):900-10. PubMed ID: 5785170
[No Abstract] [Full Text] [Related]
16. Treatment of shock associated with myocardial infarction.
Med Lett Drugs Ther; 1969 Apr; 11(7):29-31. PubMed ID: 5781647
[No Abstract] [Full Text] [Related]
17. Clinical appraisal of shock following acute myocardial infarction.
Mir MA; Rees S; Yahya AM; Williams JD; Reeves TL
Cardiology; 1974; 59(2):69-82. PubMed ID: 4434361
[No Abstract] [Full Text] [Related]
18. Vasopressors and other drugs used in shock.
Br Med J; 1970 Sep; 3(5725):756-7. PubMed ID: 5472761
[No Abstract] [Full Text] [Related]
19. Management of shock in acute myocardial infarction.
Pema PJ
J Am Osteopath Assoc; 1971 Mar; 70(7):692-702. PubMed ID: 4926966
[No Abstract] [Full Text] [Related]
20. [Central venous pressure in control of cardiogenic shock].
Gavrilescu S; Cotoi S; Riviş I
Med Interna (Bucur); 1968 Nov; 20(11):1361-8. PubMed ID: 5731992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
